Axed Covid vaccine contract cost taxpayers £358m
The IndependentGet the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A biotechnology company which had its contract to make Covid vaccines cancelled by the UK Government still received £358 million of taxpayers’ money, it has emerged. A form filed with the United States Securities and Exchange Commission states Valneva received advances totalling £358 million as part of its agreement with the UK Government. It shows the company received around £40.5 million under a settlement agreement, another £66.5 million to cover capital expenditure, and the remainder related to prepayments for vaccine doses. A spokesperson for Valneva said: “Valneva is exploring options for its Almeida manufacturing facility in Livingston, initially built to produce its Covid-19 vaccine, including a possible sale or a re-purposing to produce its vaccine for Japanese encephalitis, and its chikungunya vaccine, if approved.” The UK Government has been approached for comment.